The proton–proton elastic differential cross section
d
σ
/
d
t
has been measured by the TOTEM experiment at
s
=
2.76
TeV
energy with
β
∗
=
11
m
beam optics. The Roman Pots were inserted to 13 times ...the transverse beam size from the beam, which allowed to measure the differential cross-section of elastic scattering in a range of the squared four-momentum transfer (|
t
|) from 0.36 to
0.74
GeV
2
. The differential cross-section can be described with an exponential in the |
t
|-range between 0.36 and
0.54
GeV
2
, followed by a diffractive minimum (dip) at
|
t
dip
|
=
(
0.61
±
0.03
)
GeV
2
and a subsequent maximum (bump). The ratio of the
d
σ
/
d
t
at the bump and at the dip is
1.7
±
0.2
. When compared to the proton–antiproton measurement of the D0 experiment at
s
=
1.96
TeV
, a significant difference can be observed. Under the condition that the effects due to the energy difference between TOTEM and D0 can be neglected, the result provides evidence for the exchange of a colourless C-odd three-gluon compound state in the
t
-channel of the proton–proton and proton–antiproton elastic scattering.
Stimulated Raman scattering, two-photon absorption, free-carrier dispersion, self-phase and cross-phase modulations induced by the Kerr effect, walk-off, pump depletion, and polarization coupling are ...investigated theoretically in silicon-on-insulator optical waveguides. The influence of submicrometer-scale rib waveguide sizes on the time-space evolution of both pump and fundamental and higher order Stokes' picosecond pulses is presented. Finally, the threshold conditions for higher order Stokes' waves have been found and interpolated by a simple formula.
Visceral leishmaniasis (VL) is an extremely rare example of opportunistic infection in patients treated with TNF-alpha antagonists and only a few cases have been described. In this paper risk ...factors, clinical features, diagnostic work-up and outcome of patients developing VL under biologic therapy are described.
Case report and review of the published cases of VL in patients under biologic treatment.
We retrieved six patients, including ours, all of whom presented anarchic fever and pancytopenia. In 5 cases, splenomegaly was detected. The same number of patients came from endemic areas for VL. In the majority of the cases a bone marrow examination was not diagnostic, requiring the performance of a second one and/or the execution of other diagnostic tests. One fatal outcome was observed.
Even if VL represents a sporadic complication of biologic treatments, its presence should always be suspected in patients developing a triad of signs and symptoms constituted by fluctuant fever, pancytopenia and splenomegaly, especially if coming from endemic areas. In these cases an extensive diagnostic work-up must be warranted. Atypical and confusing features may resemble autoimmune diseases at presentation and during the course of the illness.
PDF
